Hospital
Brookville Hospital
Brookville Hospital was paid $1.19M by Medicaid between Nov 2019 and Dec 2024, across 79 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 30% of everything it billed.
33Billing provider infoBROOKVILLE HOSPITAL
BROOKVILLE, PA 15825
BROOKVILLE, PA 15825
33aNPI1760452924assigned 01/23/2006
33bProvider typeCritical Access Hospital
28Total paid$1.19M
24GClaims35,922
24DCodes billed79
24AFirst – last monthNov 2019 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Pennsylvania
Rank by total paid#7 of 12
Median peer was paid$1.19M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 29 | $6.48 | |
| 2020 | 2,986 | $82K | |
| 2021 | 17,407 | $499K | |
| 2022 | 6,160 | $264K | |
| 2023 | 5,232 | $188K | |
| 2024incomplete | 4,108 | $161K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 30% | 6,410 | 4,969 | $362K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 3,763 | 3,504 | $287K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 1,692 | 1,577 | $195K |
| 87631 | 4.7% | 392 | 380 | $56K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.2% | 321 | 297 | $50K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.0% | 679 | 660 | $24K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 232 | 206 | $19K |
| 80053 | Comprehensive metabolic panel | 1.5% | 1,817 | 1,648 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 1,610 | 840 | $18K |
| 80050 | General health panel | 1.1% | 272 | 270 | $13K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 254 | 247 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,584 | 1,556 | $11K |
67 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,180 | $11K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 123 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 385 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 257 | $10K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 778 | $9K |
| 80061 | Lipid panel | <1% | 527 | $7K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 208 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 270 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 381 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 60 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 456 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 191 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 398 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 357 | $3K |
| 84484 | <1% | 309 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 186 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 325 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 92 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 334 | $2K |
| 83735 | <1% | 341 | $2K | |
| 81001 | <1% | 737 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 16 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 611 | $2K |
| 86618 | <1% | 49 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 15 | $1K |
| 84439 | <1% | 119 | $1K | |
| 71250 | <1% | 17 | $914.10 | |
| 83690 | <1% | 186 | $903.50 | |
| 80076 | <1% | 96 | $792.60 | |
| 82570 | <1% | 113 | $778.41 | |
| 82043 | <1% | 94 | $757.85 | |
| 87077 | <1% | 108 | $719.54 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 18 | $675.96 |
| 87186 | <1% | 87 | $668.00 | |
| 81003 | <1% | 219 | $647.25 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $643.92 |
| 83540 | <1% | 66 | $557.15 | |
| 86140 | <1% | 173 | $509.33 | |
| 85610 | <1% | 166 | $496.40 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 41 | $471.60 |
| 73610 | <1% | 24 | $453.20 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,052 | $432.77 |
| 85652 | <1% | 145 | $429.30 | |
| 85027 | <1% | 61 | $405.89 | |
| 87081 | <1% | 66 | $367.31 | |
| 74018 | <1% | 26 | $359.60 | |
| 85379 | <1% | 36 | $331.78 | |
| 82728 | <1% | 28 | $330.00 | |
| 83605 | <1% | 40 | $286.40 | |
| 73030 | <1% | 15 | $235.95 | |
| G0008 | Administration of influenza virus vaccine | <1% | 22 | $231.00 |
| 84703 | <1% | 25 | $224.77 | |
| 81025 | <1% | 53 | $214.80 | |
| 90686 | <1% | 13 | $159.06 | |
| 82607 | <1% | 14 | $157.30 | |
| 85730 | <1% | 27 | $148.14 | |
| 83550 | <1% | 27 | $137.50 | |
| 73130 | <1% | 12 | $123.05 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 719 | $97.93 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 150 | $79.99 |
| 36415 | Collection of venous blood by venipuncture | <1% | 293 | $38.19 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 468 | $33.95 |
| 3078F | 0% | 635 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 89 | $0.00 |
| 3074F | 0% | 1,128 | $0.00 | |
| 3079F | 0% | 420 | $0.00 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 207 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPEER, JULIANNE (PRESIDENT)
Parent organizationDUBOIS REGIONAL MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| Brookville Hospital | Philipsburg, PA | $2.85M |
| Brookville Hospital | Fairmount City, PA | $286K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.